{"id":"NCT01188798","sponsor":"St. Jude Children's Research Hospital","briefTitle":"Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies","officialTitle":"Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-09","primaryCompletion":"2012-02","completion":"2012-02","firstPosted":"2010-08-25","resultsPosted":"2013-03-14","lastUpdate":"2013-03-21"},"enrollment":6,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Acute Lymphoblastic Leukemia","Acute Myelocytic Leukemia","Chronic Myelocytic Leukemia","Hodgkin's Disease","Myelodysplastic Syndrome"],"interventions":[{"type":"DRUG","name":"Methotrexate","otherNames":[]},{"type":"DRUG","name":"Pentostatin","otherNames":[]}],"arms":[{"label":"Transplant recipients receiving Methotrexate","type":"EXPERIMENTAL"},{"label":"Transplant recipients receiving Pentostatin","type":"EXPERIMENTAL"}],"summary":"The purpose of the study is to determine if participants who receive the GVHD prophylaxis medication pentostatin will have less severe hepatic toxicities than those receiving MTX. The study is estimated to have sufficient statistical power to ascertain at least a 20% improvement in day 42 NCI CTC grade 2 or above hepatic toxicity-free survival in pentostatin recipients.","primaryOutcome":{"measure":"Determining Whether the Hepatic Adverse Event-free (NCI Grades II-IV) Survival at Day 42 After an HLA-matched Transplant for Hematologic Malignancy Can be Improved by Using a GVHD Prophylaxis Regimen That Includes Pentostatin Rather Than MTX.","timeFrame":"42 days post-transplant","effectByArm":[],"pValues":[]},"eligibility":{"minAge":"18 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":24,"exclusionCount":1},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["http://www.stjude.org"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":2},"commonTop":["Epistaxis","Mucositis","Febrile Neutropenia","Infection, Clostridium Difficile, Stool","Cytokine Release Syndrome (Stem Cell Infusion)"]}}